The Comings & Goings column is about sharing the professional successes of our community. We want to recognize those landing new jobs, new clients for their business, joining boards of organizations and other achievements. Please share your successes with us at [email protected]. 

Congratulations to Joe Kapp named Chair of the Advisory Council of the Smithsonian Center for Folklife and Cultural Heritage. The Center is a research and educational unit of the Smithsonian that promotes greater understanding and sustainability of cultural heritage across the United States and around the world through research, education, and community engagement. It produces the Smithsonian Folklife Festival, Smithsonian Folkways Recordings, exhibitions, symposia, publications, and educational materials. It also maintains the Ralph Rinzler Folklife Archives and Collections and manages cultural heritage initiatives around the world. 

Center Director Chris Murphy said, “Joe will be a great leader for the Center as we grow our resources and expand our engagement with cultural heritage communities and the public. His expertise has already been valuable to the direction of the council in recent years. I know he will do an exceptional job.” 

Upon being named to the position, Kapp said, “I am so grateful for this unique opportunity to continue fostering the preservation and celebration of diverse cultural expressions, ensuring that the rich traditions, vibrant arts and voices of all communities around the world are recognized and cherished for generations to come. I look forward to working with the incredible team at the Center to amplify the cultural vitality that defines our shared human experience.” 

Kapp is president and cofounder of the National Center for Resource Development, a national nonprofit that helps foundations, nonprofits, higher education, and other institutions achieve greater impact by developing resources to execute their missions more effectively. He has presented to communities around the world, including at the United Nations General Assembly Science Summit. He has also taught entrepreneurship principles to organizations and institutions globally, with experience in Europe, Armenia, Colombia, Turkmenistan, Uzbekistan, Ukraine, and beyond. 

He is a co-founder of LGBT Tech, a nonprofit that develops programs and resources that support LGBTQ communities and educates organizations and policy makers on the unique needs LGBTQ individuals face when it comes to technology. He contributed a chapter to the U.S. Federal Reserve Bank’s book called Investing in Rural Prosperity. 

Delaware state Sen. Sarah McBride is poised to become the first openly transgender person elected to Congress after she won her primary on Tuesday.

McBride defeated Earl Cooper by a 79.9-16.2 percent margin in the Democratic primary for the state’s congressional seat. McBride will face Republican John Whalen in November.

The LGBTQ+ Victory Fund in a press release notes McBride is “favored to win in the heavily Democratic state.”

“Voters across the country are sick and tired of the divisive politics of the past — that’s why we’re seeing an increase in diverse, young candidates like Sarah McBride clearing their primaries,” said Victory Fund President Annise Parker. “Nobody is more qualified than Sarah to represent the values of Delaware in Congress. I look forward to celebrating Sarah’s election victory in November and seeing her get to work for her constituents in Washington.” 

McBride is poised to succeed U.S. Rep. Lisa Blunt Rochester (D-Del.), who is running for retiring U.S. Sen. Thomas Carper (D-Del.)’s seat.

“Of course, there’s going to be discussion about the potential of this campaign to break this barrier and to increase diversity in Congress and to ensure that a voice that has been totally absent from the halls of Congress is finally there in an elected capacity,” McBride told the Washington Blade during a 2023 interview after she declared her candidacy. “While it’s not what this campaign is focused on, while it’s not what voters are focused on, it is certainly relevant to the young people who are feeling alone and scared right now.”

The D.C. Department of Health and Whitman-Walker Health are closely monitoring an outbreak of a new, more virulent strain of Mpox in several African nations that prompted the World Health Organization on Aug. 15 to declare the outbreak a global health emergency.

LGBTQ health advocates in Los Angles have been working with that city’s public health officials to ensure the LGBTQ community, especially gay and bisexual men, become vaccinated with the existing Mpox vaccine, which is deemed effective in preventing or lessening the severity of an Mpox infection.

In the 2022 Mpox outbreak in the U.S., men who have sex with men accounted for the largest number of Mpox cases, with more than 90 percent of the cases occurring in men who were gay, bi, or straight.

The U.S. Centers for Disease Control and Prevention, which closely monitored and took action to curtail the 2022 Mpox outbreak in the U.S., has said no cases so far of the more virulent strain in Africa, referred to as the clade 1 strain, have been documented in the U.S.

But CDC officials, along with officials with the D.C. Department of Health, referred to as D.C. Health, and Whitman-Walker Health, say they are taking steps to ensure they are prepared if the new strain surfaces in the U.S. and in the D.C. area.

International health officials expressed concern after at least one case of a person infected with the new more virulent strain was diagnosed in Sweden, marking the first case outside the African continent. Information surfacing from Africa in August showed that at least 500 people had died from Mpox in the current outbreak.

“D.C. Health is monitoring the situation very closely and taking the necessary steps to ensure preparedness,” according to a statement released by D.C. Health to the Washington Blade

“We have treated over 300 patients with Mpox, with most of the cases occurring in 2022,” a statement released on Sept. 9 by Whitman-Walker Health says. “We continue to see sporadic cases, with 11 cases in the last year,” the statement says. It says the most recent Mpox case it has treated occurred this July.

Dr. Kyle Benda, who serves as manager of Whitman-Walker’s Sexual Medicine and Acute Rapid Treatment Clinic, said all of the Mpox patients Whitman-Walker has seen have had the less virulent strain of Mpox that surfaced in the 2022 outbreak in the U.S. and worldwide —  referred to as clade 2 Mpox.

“We have not seen any cases recently or cases we believe to be due to the clade 1 outbreak occurring in Africa,” Benda told the Blade. “We have been able to treat patients with Mpox through use of tecovirimat obtained from the CDC through their expanded access program.”

He was referring to the medication approved in 2022 by the U.S. Food and Drug Administration as an effective treatment for Mpox.

Similar to nationwide U.S. data, statistics released by D.C. Health about the demographic breakdown of the 2022-2023 Mpox outbreak in D.C. shows that men, especially African-American men, along with gay and bisexual men, made up the largest number of Mpox cases.

The D.C. data show that men made up 96.3 percent of the D.C. cases, with women making up 1.8 percent of the cases. The data show that gay men accounted for 54.8 percent of the cases, bisexuals accounted for 6.7 percent of the cases, and those whose sexual orientation was unknown accounted for 31.4 percent of the cases.

The CDC and other health experts have pointed out that Mpox is transmitted from skin-to-skin contact, including contact with someone who may have body sores and through bodily fluids, as well as from shared bedding or clothing. Sexual contact is one of the leading modes of transmission, the experts have said.

The most common symptoms, health officials have said, include pimples or blisters on the face, body, and genitals. Other symptoms include fever, chills, headaches, muscle aches, or swelling of the lymph nodes.

Benda said Mpox transmission from sexual relations, especially for gay and bisexual men, often occurs when the typical outbreak of sores or blisters on the skin occurs internally such as in the anal canal and is not immediately detectable in the early stage of the infection.

Like other health officials, LGBTQ health advocates say the most important steps to take for those at risk for Mpox, especially gay and bi men, is to get vaccinated. The vaccination requires one injection followed by a second dose injection 28 days later.

Benda said Whitman-Walker has the vaccination shots to give to anyone who feels they may be at risk for Mpox, including people who are not currently enrolled as a Whitman-Walker patient. The statement released by D.C. Health says the vaccinations are widely available throughout the city at most pharmacies and health and medical offices.

It says for those who may not have insurance coverage for the cost of the vaccination and who may be economically challenged, they can get vaccinated at the D.C. Health and Wellness center at 77 P St., N.E. 

“We encourage all of our patients who may have an increased risk of Mpox to get vaccinated, particularly patients who may have had only one dose of the two-dose series or who have not been vaccinated at all,” Whitman-Walker’s Benda told the Blade.

Health experts, including officials with D.C. Health, have said the mostly widespread access to the Mpox vaccine is what resulted in the dramatic decline in the number of cases in the U.S. and the D.C. area in late 2023 and 2024.

When asked if a booster shot may be needed for those who have been fully vaccinated in the past two years, D.C. Health said in its statement, “Currently, there is no recommendation for more than two doses in most people.” 

The statement adds, “Those with an occupational risk, like research laboratorians who handle cultures or animals contaminated with Mpox virus directly, are recommended to receive booster doses at 2 – 10 years depending on the nature of their work.”

Data released by D.C. Health shows that out of the total number of vaccinations given in D.C. as of earlier this year, 83.4 percent of those vaccinated were men and 74.5 percent of those vaccinated were gay men. The data show 12.2 percent were bisexual, and 0.9 percent were lesbian. Women consisted of 6.5 percent of D.C. residents receiving the Mpox vaccine.